UBS Group’s C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant CXAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31
Closed -$330 10222
2023
Q2
$330 Sell
31
-2,039
-99% -$21.6K ﹤0.01% 8305
2023
Q1
$21.6K Buy
2,070
+925
+81% +$9.56K ﹤0.01% 7030
2022
Q4
$11.7K Hold
1,145
﹤0.01% 8367
2022
Q3
$12K Hold
1,145
﹤0.01% 8228
2022
Q2
$11K Buy
+1,145
New +$11.5K ﹤0.01% 7890

Other funds holding CXAC.U

UBS Group's CXAC.U Position: Q3 2023 in Review

UBS Group sold out of C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant (CXAC.U) in Q3 2023, closing a stake of 31 shares — an estimated $330 sold.

UBS Group first reported a position in CXAC.U in Q2 2022 and held it in 5 quarters. The position peaked at $21.6K in Q1 2023. 4 funds tracked by Wall St. Rank hold CXAC.U as of Q3 2023.

  • UBS Group reported no remaining C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 31 C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant shares in Q3 2023, an estimated $330.
  • UBS Group first reported a position in C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant in Q2 2022 and held it in 5 quarters.
  • UBS Group's C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant position peaked at $21.6K in Q1 2023.
  • 4 funds tracked by Wall St. Rank held C5 Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.